Art

J-GLOBAL ID：201902201042740882   Reference number：19S0957517

Safety and efficacy of canakinumab in Japanese patients with phenotypes of cryopyrin-associated periodic syndrome as established in the first open-label, phase-3 pivotal study (24-week results)

Author (10)： Imagawa, Tomoyuki (Department of Paediatrics, Yokohama City University Hospital) ,  Takeshita, Saoko (Department of Paediatrics, Yokohama City University Hospital) ,  Yokota, Shumpei (Department of Paediatrics, Yokohama City University Hospital) ,  Nishikomori, Ryuta (Department of Paediatrics, Kyoto University) ,  Heike, Toshio (Department of Paediatrics, Kyoto University) ,  Takada, Hidetoshi (Department of Paediatrics, Kyushu University) ,  Hara, Toshiro (Department of Paediatrics, Kyushu University) ,  Patel, Neha (Novartis Pharmaceutical Corporation, East Hanover) ,  Kim, Dennis (Novartis Pharmaceutical Corporation, East Hanover) ,  Lheritier, Karine (Novartis Pharma AG)
Material： Clinical and Experimental Rheumatology
Volume： 31  Issue： 2  Page： 0302-0309  Publication year： 2013 
JST Material Number： SCOPUS  ISSN： 0392-856X  CODEN： CERHD 
Country of issue： Italy (ITA)  Language： English (EN)